The University of Oklahoma Health Science Center
Oklahoma City, Oklahoma 73104
We've found
8 trials
at this facility
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Femoropopliteal In-stent Restenosis Clinical Trial
Updated: 4/10/2018
JetStream Atherectomy for the Treatment of In-stent Restenosis
Status: Enrolling
Updated: 4/10/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/25/2016
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/12/2016
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Status: Enrolling
Updated: 4/12/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials